Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 138.00M | $ 96.00M | $ 255.00M | $ 140.00M | $ 340.00M |
Total Assets | $ 6.84B | $ 6.91B | $ 7.34B | $ 6.88B | $ 7.62B |
Total Debt | $ 1.48B | $ 1.35B | $ 1.23B | $ 1.33B | $ 1.47B |
Net Debt | $ 1.34B | $ 1.25B | $ 977.00M | $ 1.19B | $ 1.13B |
Total Liabilities | $ 4.99B | $ 4.41B | $ 4.96B | $ 4.50B | $ 5.32B |
Stockholders Equity | $ 1.85B | $ 2.50B | $ 2.38B | $ 2.38B | $ 2.30B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |